Better Therapeutics Inc. (BTTX) OTC MARKETS

$0.01 0 (8.53%)

Market Cap: -

As of 03/28/24 04:00 PM EDT. Market closed.

(BTTX)

Better Therapeutics Inc. (BTTX)
OTC MARKETS

$0.01
0 (8.53%)

Market Cap: -

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

better therapeutics (f/k/a farewell) is developing prescription digital therapeutics for treating chronic disease. its innovative solution combines software, human coaching augmented by artificial intelligence, and advanced analytics to address the behaviors at the root cause of most chronic conditions, in a manner that can scale rapidly to address millions of covered lives. better’s digital ... read more

better therapeutics (f/k/a farewell) is developing prescription digital therapeutics for treating chronic disease. its innovative solution combines software, human coaching augmented by artificial intelligence, and advanced analytics to address the behaviors at the root cause of most chronic conditions, in a manner that can scale rapidly to address millions of covered lives. better’s digital therapeutics are based on well-established evidence, fit within existing clinical treatment guidelines, and can be used with or without other interventions. better believes non-drug treatment options are essential to reducing the unnecessary health and cost burden of chronic disease on individuals, payers, and the nation. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
URL
Address
.
PRICE CHART FOR BETTER THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.07
Previous Close
$0.01
Days Range
$0.01 - $0.02
52 week range
- - -
Volume
899,375
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
49,861,726
Open
$0.07
Previous Close
$0.01
Days Range
$0.01 - $0.02
52 week range
- - -
Volume
899,375
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
49,861,726
FINANCIAL STATEMENTS FOR BETTER THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR BETTER THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
PERRY DAVID PExecutive ChairmanFeb 09, 2024 Option Exercise$0.19839,895160,0002,416,634Feb 13, 2024, 09:50 PM
PERRY DAVID PExecutive ChairmanJan 09, 2024 Option Exercise$0.171,471,453250,0001,576,739Jan 10, 2024, 04:19 PM
PERRY DAVID PExecutive ChairmanJul 27, 2023 Buy$0.731,233,045900,00013,030,393Jul 31, 2023, 07:59 AM
Berman Mark A.Chief Medical OfficerJul 27, 2023 Buy$0.7354,80240,000388,191Jul 31, 2023, 07:59 AM
Armanino Andrew J.DirectorJul 27, 2023 Buy$0.73274,010200,000728,368Jul 31, 2023, 07:58 AM
Granger ElderDirectorJul 27, 2023 Buy$0.7334,25125,00035,851Jul 31, 2023, 07:58 AM
KARBE FRANKChief Executive OfficerJul 27, 2023 Buy$0.73137,005100,000429,429Jul 31, 2023, 07:58 AM
Parker Geoffrey M.DirectorJul 27, 2023 Buy$0.73685,025500,0001,028,055Jul 31, 2023, 07:58 AM
Granger ElderDirectorMay 16, 2023 Buy$0.876005201,600May 18, 2023, 07:11 AM
PERRY DAVID PSee RemarksApr 10, 2023 Buy$0.823,636,3643,000,0003,636,364Apr 12, 2023, 09:44 PM
PERRY DAVID PSee RemarksApr 10, 2023 Buy$0.821,333,3331,100,00011,797,348Apr 12, 2023, 09:44 PM
KARBE FRANKSee RemarksApr 10, 2023 Buy$0.82242,424200,000292,424Apr 12, 2023, 04:15 PM
Parker Geoffrey M.DirectorApr 10, 2023 Buy$0.82303,030250,000343,030Apr 12, 2023, 04:15 PM
Armanino Andrew J.DirectorApr 10, 2023 Buy$0.82303,030250,000454,358Apr 12, 2023, 04:15 PM
Wynholds KristinChief Product OfficerNov 30, 2022 Option Exercise$1.243,7814,69298,819Dec 02, 2022, 04:15 PM
Wynholds KristinChief Product OfficerMay 31, 2022 Option Exercise$1.545,0237,72895,038Dec 02, 2022, 04:15 PM
Heinen MarkSee RemarksNov 30, 2022 Option Exercise$1.2415,72319,51285,723Dec 02, 2022, 04:15 PM
PERRY DAVID PSee RemarksSep 16, 2022 Buy$2.0739,15680,975101,536Sep 19, 2022, 06:06 AM
PERRY DAVID PSee RemarksSep 15, 2022 Buy$1.9910,84421,62362,380Sep 19, 2022, 06:06 AM
KARBE FRANKSee RemarksSep 15, 2022 Buy$2.0950,000104,69550,000Sep 15, 2022, 08:53 PM
Heinen MarkSee RemarksSep 13, 2022 Buy$1.9426,13250,69670,000Sep 14, 2022, 04:37 PM
Heinen MarkSee RemarksSep 12, 2022 Buy$1.9423,86846,30443,868Sep 14, 2022, 04:37 PM
Heinen MarkSee RemarksJun 24, 2022 Buy$1.752,2814,0012,281Jun 28, 2022, 04:24 PM
Armanino Andrew J.DirectorJun 14, 2022 Buy$1.3915,00020,84615,000Jun 16, 2022, 07:11 PM
Parker Geoffrey M.DirectorJun 13, 2022 Buy$1.4525,00036,18240,000Jun 14, 2022, 04:25 PM
Heinen MarkSee RemarksJun 10, 2022 Buy$1.565,0007,80020,000Jun 10, 2022, 06:23 PM
Armanino Andrew J.DirectorJun 09, 2022 Buy$1.6525,00041,355151,328Jun 10, 2022, 04:39 PM
Zamirowski JustinChief Commercial OfficerMay 27, 2022 Option Exercise$0.501,67783936,913Jun 01, 2022, 04:47 PM
Zamirowski JustinChief Commercial OfficerMay 16, 2022 Option Exercise$0.5035,23617,61835,236May 18, 2022, 05:12 PM
Heinen MarkSee RemarksMar 31, 2022 Buy$1.985,0009,90015,000Apr 04, 2022, 04:28 PM
Appelbaum Kevin JChief Executive OfficerMar 31, 2022 Buy$1.972,5004,9216,250Apr 04, 2022, 04:27 PM
Armanino Andrew J.DirectorMar 29, 2022 Buy$2.1440,00085,620126,328Mar 31, 2022, 04:39 PM
Parker Geoffrey M.DirectorMar 29, 2022 Buy$2.1515,00032,23015,000Mar 31, 2022, 04:38 PM
LAVIZZO-MOUREY RISA JDirectorDec 21, 2021 Buy$4.6010,00046,00010,000Dec 23, 2021, 06:20 PM
Appelbaum Kevin JChief Executive OfficerDec 20, 2021 Buy$4.601,0004,6003,750Dec 22, 2021, 06:03 PM
Appelbaum Kevin JChief Executive OfficerDec 15, 2021 Buy$4.717503,5302,750Dec 17, 2021, 08:43 PM
Parker Geoffrey M.DirectorDec 14, 2021 Buy$4.9420,00098,80053,333Dec 16, 2021, 04:32 PM
Heinen MarkSee RemarksDec 14, 2021 Buy$5.445002,7217,667Dec 15, 2021, 04:53 PM
Heinen MarkSee RemarksDec 13, 2021 Buy$5.455002,7257,167Dec 15, 2021, 04:53 PM
Heinen MarkSee RemarksDec 15, 2021 Buy$4.702,33310,95310,000Dec 15, 2021, 04:53 PM
Armanino Andrew J.DirectorDec 13, 2021 Buy$5.4821,000115,06786,328Dec 15, 2021, 04:45 PM
Appelbaum Kevin JChief Executive OfficerDec 10, 2021 Buy$5.981,0005,9752,000Dec 14, 2021, 05:32 PM
Granger ElderDirectorDec 03, 2021 Buy$6.661,0006,6601,000Dec 07, 2021, 04:23 PM
Appelbaum Kevin JChief Executive OfficerDec 03, 2021 Buy$6.435003,2131,000Dec 06, 2021, 05:34 PM
Appelbaum Kevin JChief Executive OfficerDec 02, 2021 Buy$6.845003,420500Dec 06, 2021, 05:34 PM
Armanino Andrew J.DirectorNov 29, 2021 Buy$6.9617,000118,32065,328Dec 01, 2021, 04:42 PM
Liu SuyingChief Executive OfficerApr 07, 2021 Sale$9.00200,0001,800,0001,374,000Apr 09, 2021, 06:32 PM
Mountain Crest Capital LLC10% OwnerApr 07, 2021 Sale$9.00200,0001,800,0001,374,000Apr 09, 2021, 06:31 PM
Liu DongChief Financial OfficerApr 07, 2021 Sale$9.00200,0001,800,0001,374,000Apr 09, 2021, 06:31 PM
Mountain Crest Capital LLC10% OwnerJan 14, 2021 Buy$10.007,50075,0001,574,000Jan 19, 2021, 05:10 PM
Liu SuyingChief Executive OfficerJan 14, 2021 Buy$10.007,50075,0001,574,000Jan 19, 2021, 05:08 PM
Liu DongChief Financial OfficerJan 14, 2021 Buy$10.007,50075,0001,574,000Jan 19, 2021, 05:07 PM
Mountain Crest Capital LLC10% OwnerJan 12, 2021 Buy$10.00135,0001,350,0001,566,500Jan 14, 2021, 06:11 AM
Liu SuyingChief Executive OfficerJan 12, 2021 Buy$10.00135,0001,350,0001,566,500Jan 14, 2021, 06:09 AM
Liu DongChief Financial OfficerJan 12, 2021 Buy$10.00135,0001,350,0001,566,500Jan 14, 2021, 06:07 AM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
PERRY DAVID PExecutive Chairman02/09/2024160,000
PERRY DAVID PExecutive Chairman01/09/2024250,000
PERRY DAVID PExecutive Chairman07/27/2023900,000
Berman Mark A.Chief Medical Officer07/27/202340,000
Armanino Andrew J.Director07/27/2023200,000
Granger ElderDirector07/27/202325,000
KARBE FRANKChief Executive Officer07/27/2023100,000
Parker Geoffrey M.Director07/27/2023500,000
Granger ElderDirector05/16/2023520
PERRY DAVID PSee Remarks04/10/20233,000,000
PERRY DAVID PSee Remarks04/10/20231,100,000
KARBE FRANKSee Remarks04/10/2023200,000
Parker Geoffrey M.Director04/10/2023250,000
Armanino Andrew J.Director04/10/2023250,000
Wynholds KristinChief Product Officer11/30/20224,692
Wynholds KristinChief Product Officer05/31/20227,728
Heinen MarkSee Remarks11/30/202219,512
PERRY DAVID PSee Remarks09/16/202280,975
PERRY DAVID PSee Remarks09/15/202221,623
KARBE FRANKSee Remarks09/15/2022104,695
Heinen MarkSee Remarks09/13/202250,696
Heinen MarkSee Remarks09/12/202246,304
Heinen MarkSee Remarks06/24/20224,001
Armanino Andrew J.Director06/14/202220,846
Parker Geoffrey M.Director06/13/202236,182
Heinen MarkSee Remarks06/10/20227,800
Armanino Andrew J.Director06/09/202241,355
Zamirowski JustinChief Commercial Officer05/27/2022839
Zamirowski JustinChief Commercial Officer05/16/202217,618
Heinen MarkSee Remarks03/31/20229,900
Appelbaum Kevin JChief Executive Officer03/31/20224,921
Armanino Andrew J.Director03/29/202285,620
Parker Geoffrey M.Director03/29/202232,230
LAVIZZO-MOUREY RISA JDirector12/21/202146,000
Appelbaum Kevin JChief Executive Officer12/20/20214,600
Appelbaum Kevin JChief Executive Officer12/15/20213,530
Parker Geoffrey M.Director12/14/202198,800
Heinen MarkSee Remarks12/14/20212,721
Heinen MarkSee Remarks12/13/20212,725
Heinen MarkSee Remarks12/15/202110,953
Armanino Andrew J.Director12/13/2021115,067
Appelbaum Kevin JChief Executive Officer12/10/20215,975
Granger ElderDirector12/03/20216,660
Appelbaum Kevin JChief Executive Officer12/03/20213,213
Appelbaum Kevin JChief Executive Officer12/02/20213,420
Armanino Andrew J.Director11/29/2021118,320
Liu SuyingChief Executive Officer04/07/20211,800,000
Mountain Crest Capital LLC10% Owner04/07/20211,800,000
Liu DongChief Financial Officer04/07/20211,800,000
Mountain Crest Capital LLC10% Owner01/14/202175,000
Liu SuyingChief Executive Officer01/14/202175,000
Liu DongChief Financial Officer01/14/202175,000
Mountain Crest Capital LLC10% Owner01/12/20211,350,000
Liu SuyingChief Executive Officer01/12/20211,350,000
Liu DongChief Financial Officer01/12/20211,350,000
Load More Insider Transactions
FUNDS WITH A POSITION IN BETTER THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
GEODE CAPITAL MANAGEMENT, LLC168,8210%57.96%Other
BLACKROCK INC.88,6350%-0.44%Other
CHANGE IN SHARES OUTSTANDING FOR BETTER THERAPEUTICS INC
STOCK BUYBACKS FOR BETTER THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2022
63.16%
5Q
09/30/2023
03/31/2022
64.42%
6Q

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2022
63.16%
5Q
03/31/2022
64.42%
6Q
BUYBACK ANNOUNCEMENT(S) FOR BETTER THERAPEUTICS INC
LOADING...